Soru

Zorluk: OrtaPreventive Care and Screening

An occupational health clinic is auditing the medical records of several newly onboarded employees to ensure compliance with age- and risk-appropriate preventive care protocols. Match each employee's clinical profile with their most urgently indicated evidence-based screening or immunization intervention.

  • A 67-year-old male who smoked two packs of cigarettes daily for 20 years before ceasing a decade ago; no prior vascular imaging on record.Yearly low-radiation thoracic computed tomography and a single ultrasound assessment of the abdominal aorta.
  • A 41-year-old male whose father was diagnosed with a colonic malignancy at age 48.Direct referral for optical colonoscopy with a recommended surveillance interval of five years.
  • A 45-year-old female currently receiving a monoclonal antibody targeting TNF-alpha for severe psoriasis.Administration of inactivated pneumococcal and recombinant zoster vaccines, avoiding attenuated formulations.
  • A 36-year-old female whose last preventive reproductive health visit was five years ago, yielding normal standalone cellular cytology.Uterine cervix surveillance utilizing high-risk viral testing, cellular cytology, or a combination of both.
  • A 66-year-old female, strictly up-to-date on age-appropriate malignancy surveillance, presenting for her initial senior wellness assessment.Bone densitometry testing for baseline skeletal fracture risk stratification.

Cevap

The 67-year-old former smoker matches with lung and AAA screening; the 41-year-old with a family history of early CRC matches with optical colonoscopy; the 45-year-old on biologic therapy matches with non-live immunizations; the 36-year-old overdue for a Pap smear matches with cervical surveillance; and the healthy 66-year-old female matches with bone densitometry.
Each patient's clinical profile aligns precisely with current USPSTF and ACIP guidelines. The 67-year-old former heavy smoker requires dual screening for lung cancer and an abdominal aortic aneurysm. The 41-year-old with a strong family history requires high-risk optical colonoscopy. The immunosuppressed 45-year-old must receive non-live pneumococcal and zoster vaccines. The 36-year-old is overdue for cervical surveillance following a 5-year gap since a standalone cytology. The 66-year-old female meets the age threshold for baseline osteoporosis screening.

Adım Adım Çözüm

1
Analyze the 67-year-old male's smoking history and demographic profile.
Patient has a 40 pack-year smoking history, quit 10 years ago, and is a male over 65.
Determines eligibility for both annual low-dose chest CT (age 50-80, 20+ pack-years, quit <15 years ago) and one-time AAA ultrasound (men 65-75 with any smoking history).
2
Assess the 41-year-old male's familial risk for colorectal cancer.
Identified a first-degree relative diagnosed at age 48.
Shifts management to high-risk screening, requiring colonoscopy at age 40 (or 10 years prior to the relative's diagnosis) and repeating every 5 years.
3
Evaluate the immunization needs of the 45-year-old female on a TNF-alpha inhibitor.
Patient is actively immunosuppressed due to targeted biologic therapy.
Indicates the need for pneumococcal vaccination and the recombinant zoster vaccine (>19 years old for immunocompromised), while mandating the avoidance of live-attenuated vaccines.
4
Review the cervical screening timeline for the 36-year-old female.
The last documented screening was cytology alone 5 years ago.
Identifies the patient as overdue, as cytology alone requires a 3-year interval. She now requires standard screening (hrHPV, cytology, or co-testing).
5
Determine the standard age-based screening for the healthy 66-year-old female.
Patient is female and >65 years old with no prior fracture history.
Triggers the USPSTF recommendation for baseline osteoporosis screening via bone densitometry.

Anahtar Kavram

Evidence-based preventive care and screening guidelines tailored to patient age, sex, familial risk factors, and iatrogenic immunosuppression.
Bu soruyu puanla